{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/common-cold/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"13da7724-388f-5083-87a4-d197fad621d3","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field ce746915-6e4e-4c3f-9ddf-e88aa801ce70 --><h2>Changes</h2><!-- end field ce746915-6e4e-4c3f-9ddf-e88aa801ce70 -->","summary":null,"htmlStringContent":"<!-- begin item a03b5507-eaad-490d-80b1-73cc70fc09eb --><!-- begin field efed1f8d-a961-4a7f-b38f-cd85ef0e11c8 --><div><strong>July to August 2016</strong> — reviewed. A literature search was conducted in July 2016 to identify evidence-based guidelines, UK policy, systematic reviews, and key randomized controlled trials published since the last revision of the topic. No major changes to clinical recommendations have been made, although minor restructuring of the topic has been undertaken.</div><!-- end field efed1f8d-a961-4a7f-b38f-cd85ef0e11c8 --><!-- end item a03b5507-eaad-490d-80b1-73cc70fc09eb -->","topic":{"id":"9b78695c-3c64-5770-bf35-1ee5cf2cb29f","topicId":"5aee85d5-d8d1-479b-bfa3-a30835b97d6e","topicName":"Common cold","slug":"common-cold","lastRevised":"Last revised in August 2016","chapters":[{"id":"2d71e136-2d58-5131-b317-e17dfa10407a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"68f3d785-7f34-53dc-8693-fac9f8cf0b83","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"80ffc4ec-68ee-5b3c-85de-9b0b2c0727cd","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"13da7724-388f-5083-87a4-d197fad621d3","slug":"changes","fullItemName":"Changes"},{"id":"f8e94edd-fbab-509e-a4a6-bcaeaee3a12e","slug":"update","fullItemName":"Update"}]},{"id":"845c4165-0e4b-54b7-ad0d-4a3f8ce0dba1","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"58640184-7105-5c0b-ba03-9ac3c8039df6","slug":"goals","fullItemName":"Goals"},{"id":"b7861ff1-501e-5737-93f3-92d5e0dd1b85","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8de0aa85-b6cc-5f52-b748-4ffd3122e588","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8c040833-f111-5821-a361-8c6e8971d947","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0a34aff3-ba2e-5669-b5db-838f0f362dcf","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"37093313-70f3-5f75-91f7-5be0831b32fb","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"eaa30267-8e53-5abf-8ad1-72db861b9f26","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"82740581-ed8b-5193-99f7-b233c7b7168b","slug":"definition","fullItemName":"Definition"},{"id":"0c9cc525-5128-5e46-a30e-79addf37388d","slug":"complications","fullItemName":"Complications"},{"id":"97ad0093-c0b4-5459-bcc3-8075819fe57e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"619eae6e-4425-5457-b95d-3e0fe3df38af","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"0e772b83-eb60-572c-8aba-eda986114860","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"de4542d4-eadb-58d2-8a3e-518b0f5db16d","slug":"diagnosis-in-adults-older-children","fullItemName":"Diagnosis in adults and older children"},{"id":"2065bcd2-a2dd-57b9-a7a7-68cc0f02dd4b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"acb6f0c8-1362-53a1-a5c6-2c88f6dcd884","slug":"diagnosis-in-younger-children-infants","fullItemName":"Diagnosis in younger children and infants"}]},{"id":"5671b781-6df7-562c-bcc5-4512a4c9e87b","fullItemName":"Management","slug":"management","subChapters":[{"id":"918d4e1d-04ea-55d6-921d-1fb60d9ef655","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"6c968d83-9ed7-5f48-9826-507f18c0164c","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"edbddcd1-73e3-5ed4-bdf1-bafa5f1f1ba4","slug":"paracetamol","fullItemName":"Paracetamol"},{"id":"2791a821-42bd-565f-ac20-bd44ad4ede92","slug":"ibuprofen","fullItemName":"Ibuprofen"}]},{"id":"2977772c-75a3-5d12-904f-1f0656c66b16","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"c5ceeaed-a580-5e23-a897-dc5e657814c5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0aa676f7-343f-5fcc-b5ae-cbdff070eb86","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c4da17f2-12fb-59ac-be32-b10d7da360b5","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"0f82fd8b-82f4-5d12-8c6f-044d21628edc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"881feb2e-6862-57b2-9c84-650136d4604e","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"23a8e26b-fd6f-5bce-bd0f-169e08be2c98","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d6105ea0-66a6-5bd6-9d2c-edc57bdc708d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"80ffc4ec-68ee-5b3c-85de-9b0b2c0727cd","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"077b6aa6-a9a0-550e-8d7e-2a1983f10511","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field b7119607-4281-47e2-9513-5fc7b726f101 --><h3>Previous changes</h3><!-- end field b7119607-4281-47e2-9513-5fc7b726f101 -->","summary":null,"htmlStringContent":"<!-- begin item 2df8b41a-dd27-450e-bd7b-dd38726b572a --><!-- begin field f00fb702-bdf0-4bc1-b3d4-05a9591e1c24 --><p><strong>July 2015 </strong>— minor update. Links to the topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a> have been added to the sections on Drug treatment and Prescribing information.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic in line with the National Institute for Health and Care Excellence (NICE) guidelines on <em>Key therapeutic topics - medicines management</em>, 2015.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic in line with the National Institute for Health and Care Excellence (NICE) guidelines on <em>Key therapeutic topics - medicines management</em>, 2012.</p><p><strong>October 2011 </strong>— reviewed. A literature search was conducted in October 2011 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of the topic. No changes to clinical recommendations have been made. Issued in November 2011.</p><p><strong>July 2011 </strong>— minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency. Prescriptions have been updated to reflect the revised dosing. Issued in July 2011.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic in line with the National Institute for Health and Care Excellence (NICE) guidelines on <em>Key therapeutic topics - medicines management, 2011</em>. Issued in June 2011.</p><p><strong>October 2010 </strong>— technical update. The management section of this topic has been simplified to improve clarity and navigation. There have been no changes to the clinical content or meaning of the recommendations.</p><p><strong>March 2009 </strong>— minor update. New advice from the Medicines and Healthcare products Regulatory Agency (MHRA) regarding over-the-counter cough and cold medicines for children has been added, specifically that certain antitussives, expectorants, nasal decongestants, and antihistamines should not be used in children under 6 years of age. Issued in April 2009.</p><p><strong>January to May 2007 </strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. There are no major changes to the recommendations for management of the common cold. More detail has been added about the diagnosis of the common cold, the differential diagnosis, complications that may occur, and the use of common remedies.</p><p><strong>October 2006 </strong>— minor update. Analgesia prescriptions updated because new doses of ibuprofen for children are recommend by the <em>British National Formulary. </em>Issued in October 2006.</p><p><strong>October 2005 </strong>— minor technical update. Issued in November 2005.</p><p><strong>January 2004 </strong>— written. Validated in March 2004 and issued in June 2004.</p><!-- end field f00fb702-bdf0-4bc1-b3d4-05a9591e1c24 --><!-- end item 2df8b41a-dd27-450e-bd7b-dd38726b572a -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}